First Trust Advisors LP Selecta Biosciences Inc Transaction History

First Trust Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.04 - $1.4 $3,206 - $4,316	3,083 Added 1.01%	308,650 $345,000
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $26,797 - $44,040	23,302 Added 8.26%	305,567 $424,000
Q4 2022 Feb 09, 2023	SELL	$0.96 - $1.6 $18,228 - $30,380	-18,988 Reduced 6.3%	282,265 $318,000
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $400,666 - $783,257	301,253 New	301,253 $494,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.